Abstract
Scintillating nanoparticles (ScNPs) are considered promising due to their potential to be coupled with photosensitizers (PS) for use in X-ray-activated photodynamic therapy (X-PDT) and/or radionuclide-activated therapy. However, most PSs with high capacity for reactive oxygen species (ROS) generation absorb light mainly in the blue region, and there are few ScNPs with high scintillation e…